Navigation Links
Vilcek prizes in biomedical science awarded
Date:3/9/2010

New York, N.Y., March 09, 2010 The Vilcek Foundation is pleased to announce the granting of the 2010 Vilcek Prize for Biomedical Science to Dr. Alexander Varshavsky, the Howard & Gwen Laurie Smits Professor of Cell Biology at California Institute of Technology, for elucidating the process and biological significance of regulated protein degradation in living cells. Another Vilcek Prize, for Creative Promise, is awarded annually to a scientist aged 38 years or younger. It will be given to Dr. Harmit Malik, Associate Member of the Fred Hutchinson Cancer Research Center, for his research on the co-evolution of humans and diseases. The Vilcek Prize is a cash award of $50,000 and an individually designed trophy; the Vilcek Prize for Creative Promise is a cash award of $25,000. Created by Stefan Sagmeister, the trophy is a 12-inch spire, reflecting the upward journey of the immigrant experience in the United States. Both prizes are awarded only to foreign-born American citizens to reflect the guiding philosophy, values, and mission of the Vilcek Foundation and its founders Dr. Jan and Marica Vilcek -- who immigrated to this country from Czechoslovakia in the 1960's.

The Vilcek Prize in Biomedical Science has been awarded annually since 2006 to an established biomedical scientist whose work has profoundly advanced science over the course of his or her career. Dr. Varshavsky's research on the ubiquitin system led to the discovery of its fundamentally important biological functions in living cells, demonstrating that the regulated protein degradation underlies major physiological processes. Today, the study of ubiquitin has major implications for research into the causes of birth defects, neuro-degenerative syndromes, cancer, and immune disorders. As a pioneer and leader in the field of ubiquitin research who has ushered it into the age of molecular genetics, Dr. Varshavsky has also helped establish this field as one of the most important and "ubiquitous" in biomedical science, a point of convergence for disparate disciplines.

Since 2009, the Vilcek Foundation also awards a Vilcek Prize for Creative Promise to a research scientist who has demonstrated significant creativity and originality in the early stages of his/her career. Dr. Harmit Malik studies genetic conflict, battles raging within a cell's nucleus as genes compete for evolutionary dominance. He uses biochemistry and genomics to study the causes and consequences of these genetic conflicts in yeast, fruit flies and other model organisms. This original and imaginative approach to genetic conflict has led to new ways of examining why humans are susceptible to cancer and other diseases, as well as to the development of a new field called paleovirology the study of ancient viruses.

"Both Dr. Varshavsky and Dr. Malik have impacted biomedical science through their innovative, breakthrough research," said Dr. Jan Vilcek, President of the Vilcek Foundation and renowned microbiologist at NYU Langone Medical Center. "My wife Marica and I are pleased to honor them not only for their extraordinary achievements in the field of biomedical science, but also as American immigrants who have made important contributions to society."


'/>"/>

Contact: Beth Amorosi
bethamorosi@yahoo.com
917-208-7489
Vilcek Foundation
Source:Eurekalert

Related biology news :

1. Dr. Harmit Malik receives Vilcek Prize for creative promise in biomedical science
2. WIREs win 3 prizes at the PROSE awards
3. Columbia University Medical Center announces 2009 Katz Prizes in Cardiovascular Research
4. Heinz Maier-Leibnitz Prizes 2009: Six young researchers recognized for outstanding achievements
5. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
6. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
7. New biomedical engineering chair earns high honors
8. New material mimics bone to create better biomedical implants
9. Finland invests €1.85 million in pan-European infrastructure for biomedical research
10. OSA to launch new journal: Biomedical Optics Express
11. Biomedical Engineering Societys new journal to be published by Springer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil and criminal ... monitoring, announced today that it has offered a challenge ... technology judge determine who has the largest and best ... platform, and the best customer service. "ICSolutions ... we do – which clearly is not the case ...
(Date:11/16/2016)... 2016 Sensory Inc ., a ... for consumer electronics, and VeriTran , a ... industry, today announced a global partnership that will ... authenticate users of mobile banking and mobile payments ... software which requires no specialized biometric scanners, yet ...
(Date:11/14/2016)... 2016  xG Technology, Inc. ("xG" or the "Company") ... communications for use in challenging operating environments, announced its ... Management will hold a conference call to discuss these ... Time (details below). Key Recent Accomplishments ... binding agreement to acquire Vislink Communication Systems. The purchase ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... Diego (PRWEB) , ... December 07, 2016 , ... ... data from its phase I/II dose escalation and expansion clinical trial for its ... in Vienna, Austria. The purpose of the trial was to determine the safety, ...
(Date:12/7/2016)... , Dec. 7, 2016 Neogen Corporation ... named Dr. Dan Kephart as its chief ... Kephart will assume his responsibilities at Neogen effective Jan. ... development director for the agribusiness unit of Thermo Fisher ... development at Life Technologies. His extensive industry experience also ...
(Date:12/7/2016)... 2016  Nordion, a standalone business of Sterigenics ... today,s award by the United States Department of ... the Phase II cooperative agreement funding to GA ... University of Missouri Research Reactor Center (MURR ® ... establishment of a new, reliable supply of molybdenum ...
(Date:12/7/2016)... 7, 2016  Vyriad Inc. announced today the appointment ... Board of Directors. "We are delighted to ... business and develop our oncolytic viruses as the next ... Stephen Russell , MD, PhD, CEO of Vyriad. "Al ... vision and passion for making a difference for cancer ...
Breaking Biology Technology: